UFIS-SWE-IG
0.1.0 - ci-build

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

Example Bundle: Suscard25mgbuckaltablett-SE-PLC-MPD-BBDL

Suscard 2,5 mg buckaltablett

MPID: SE-100002766-00010409
EURDID: 1552

Full name: Suscard 2,5 mg buckaltablett

- Invented name part: Suscard

- Strength part: 2.5 mg

- Pharmaceutical dose form part: buckaltablett

Name usage: Swedish (Kingdom of Sweden)

Authorised dose form: Buccal tablet

Legal status of supply: Medicinal product subject to medical prescription

Domain: Human use

Resource status: Current

Product classification:

  • 100000094611 glyceryl trinitrate

Marketing Authorisation 1 of 1

Authorisation number: 10409

Region: Kingdom of Sweden

Marketing authorisation holder: Evolan Pharma AB

Identifier:

  • LOC-100016200

Status: Valid (1986-06-13)

Package 1 of 2

PCID:

Description:
Blister, 30 buckaltabletter

Marketing status:

  • Kingdom of Sweden: Marketed

Pack size:

  • 30 Tablet

Package: 1 Box (Cardboard)

Containing:

Package: 3 Blister (Aluminium) (PolyVinyl Chloride)

Containing: 3 Blister

Manufactured Item

Dose form: Buccal tablet

Unit of presentation: Tablet

Ingredient

Role: Active

Substance: Glyceryl trinitrate

Presentation strength: 2.5 milligram(s) / 1 Tablet

Reference strength:
Glyceryl trinitrate 2.5 milligram(s) / 1 Tablet

Package 2 of 2

PCID:

Description:
Blister, 90 buckaltabletter

Marketing status:

  • Kingdom of Sweden: Marketed

Pack size:

  • 90 Tablet

Package: 1 Box (Cardboard)

Containing:

Package: 9 Blister (Aluminium) (PolyVinyl Chloride)

Containing: 9 Blister

Manufactured Item

Dose form: Buccal tablet

Unit of presentation: Tablet

Ingredient

Role: Active

Substance: Glyceryl trinitrate

Presentation strength: 2.5 milligram(s) / 1 Tablet

Reference strength:
Glyceryl trinitrate 2.5 milligram(s) / 1 Tablet

Administrable Product (1 of 1)

Dose form: Buccal tablet

Unit of presentation:

Route of administration:

  • Buccal use

Ingredients:

Ingredient

Role: Active

Substance: Glyceryl trinitrate

Presentation strength: 2.5 milligram(s) / 1 Tablet

Reference strength:
Glyceryl trinitrate 2.5 milligram(s) / 1 Tablet